Tzelepis George E, Kelekis Nikolaos L, Plastiras Sotiris C, Mitseas Panayiotis, Economopoulos Nikolaos, Kampolis Christos, Gialafos Elias J, Moyssakis Ioannis, Moutsopoulos Haralampos M
University of Athens Medical School, Laiko University Hospital, Athens, Greece.
Arthritis Rheum. 2007 Nov;56(11):3827-36. doi: 10.1002/art.22971.
To assess the prevalence and pattern of myocardial fibrosis as detected by delayed enhanced magnetic resonance imaging (DE-MRI) in patients with systemic sclerosis (SSc), and to evaluate a possible association between myocardial fibrosis and cardiac arrhythmias.
Forty-one patients with SSc underwent 24-hour Holter monitoring, Doppler echocardiography, and DE-MRI following gadolinium administration.
Technically acceptable DE-MRIs were obtained in 36 patients with SSc. Enhancement on DE-MRI, consistent with myocardial fibrosis, was observed in 24 of these patients (66%), and it was invariably midwall with a linear pattern, mostly involving basal and midcavity segments of the left ventricle. The volume of enhancement (total volume percentage index [TVPI]) did not differ between patients with diffuse SSc and those with limited SSc (mean +/- SD 1.46 +/- 1.73% versus 1.44 +/- 1.77%; P = 0.98). Patients with a long duration (> or = 15 years) of Raynaud's phenomenon had a greater number of enhancing segments (mean +/- SD 6.55 +/- 4.93 versus 2.96 +/- 3.46; P = 0.017) and a greater TVPI (mean +/- SD 2.44 +/- 1.97% versus 1.02 +/- 1.43%; P = 0.02) than those with a duration of Raynaud's phenomenon <15 years. Nineteen patients with SSc (53%) had abnormal Holter study results. Compared with patients with normal Holter study results, those with abnormal results had a greater number of enhancing segments (mean +/- SD 5.4 +/- 4.8 versus 2.5 +/- 2.9; P < 0.05) and a greater TVPI (mean +/- SD 2.1 +/- 1.9% versus 0.8 +/- 1.2%; P < 0.05).
DE-MRI can identify myocardial fibrosis in a significant percentage of patients with SSc and may be a useful noninvasive tool for determining cardiac involvement.
通过延迟增强磁共振成像(DE-MRI)评估系统性硬化症(SSc)患者心肌纤维化的患病率和模式,并评估心肌纤维化与心律失常之间的可能关联。
41例SSc患者在静脉注射钆剂后接受了24小时动态心电图监测、多普勒超声心动图检查以及DE-MRI检查。
36例SSc患者获得了技术上可接受的DE-MRI图像。在这些患者中,24例(66%)观察到与心肌纤维化一致的DE-MRI强化,且均为心内膜下线性强化,主要累及左心室基底部和中间腔段。弥漫性SSc患者和局限性SSc患者的强化体积(总体积百分比指数[TVPI])无差异(均值±标准差分别为1.46±1.73%和1.44±1.77%;P = 0.98)。雷诺现象病程长(≥15年)的患者与病程<15年的患者相比,强化节段数量更多(均值±标准差分别为6.55±4.93和2.96±3.46;P = 0.017),TVPI更高(均值±标准差分别为2.44±1.97%和1.02±1.43%;P = 0.02)。19例(53%)SSc患者动态心电图检查结果异常。与动态心电图检查结果正常的患者相比,结果异常的患者强化节段数量更多(均值±标准差分别为5.4±4.8和2.5±2.9;P < 0.05),TVPI更高(均值±标准差分别为2.1±1.9%和0.8±1.2%;P < 0.05)。
DE-MRI可在相当比例的SSc患者中识别心肌纤维化,可能是确定心脏受累情况的一种有用的非侵入性工具。